Verified Nov 2026
Other
·
Malvern, Pennsylvania
·
Since 2003
Neuronetics, Inc. is a medical technology company headquartered in Malvern, Pennsylvania, founded in 2003 and listed publicly under the ticker STIM. It employs between 500 and 1,000 people and reports revenue in the range of $149.2 million. The company develops transcranial magnetic stimulation systems for treating psychiatric and neurological conditions, including major depressive disorder. Its products serve the healthcare and medical equipment sector. In 2026 it announced a strategic collaboration with ANT Neuro, a neurotechnology firm.
Neuronetics, Inc. at a glance
Revenue
149.2M
Employees
500-1,000
Founded
2003
Headquarters
Malvern, Pennsylvania
Ownership
Publicly traded (NASDAQ: STIM)
Import activity
83
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
83
Named foreign suppliers
8
Top origins
China · Netherlands · Germany · Belgium
Shared foreign counterparties do not establish that these companies buy from Neuronetics, Inc..
What this tells a buyer
The record contains no customs or trade data for the company, and its most recent development is a May 2026 strategic collaboration with ANT Neuro announced through GlobeNewswire.
The company manufactures the NeuroStar Advanced Therapy System, a non-invasive transcranial magnetic stimulation device indicated for medication-resistant depression, with additional indications for OCD and adolescents aged 15 to 21.
The company trades publicly as STIM and in April 2026 saw Optum/United Behavioral Health expand coverage of NeuroStar TMS to psychiatric mental health nurse practitioners.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Neuronetics, Inc. is a medical technology company headquartered in Malvern, Pennsylvania, founded in 2003 and listed publicly under the ticker STIM. It employs between 500 and 1,000 people and reports revenue in the range of $149.2 million. The company develops transcranial magnetic stimulation systems for treating psychiatric and neurological conditions, including major depressive disorder. Its products serve the healthcare and medical equipment sector. In 2026 it announced a strategic collaboration with ANT Neuro, a neurotechnology firm.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Malvern, Pennsylvania |
Employees | 500-1,000 |
Revenue | 149.2M |
Ownership | Publicly traded (NASDAQ: STIM) |
What Neuronetics, Inc. makes
The company manufactures the NeuroStar Advanced Therapy System, a non-invasive transcranial magnetic stimulation device indicated for medication-resistant depression, with additional indications for OCD and adolescents aged 15 to 21.
Trade and customs footprint
The record contains no customs or trade data for the company, and its most recent development is a May 2026 strategic collaboration with ANT Neuro announced through GlobeNewswire. US customs bill-of-lading records list 83 inbound shipments across 8 foreign suppliers, with top origins including China · Netherlands · Germany · Belgium.
Latest developments
2026-11-04 — Neuronetics Reports Third Quarter 2026 Financial and Operating Results | Neuronetics Inc (gcs-web.com)
2026-06-15 — ANT Neuro and Neuronetics Partnership | ANT Neuro (ant-neuro.com)
2026-05-14 — Neuronetics and ANT Neuro Announce Strategic Collaboration (globenewswire.com)
2026-04-13 — Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners | Neuronetics Inc (neuronetics.com)
2026-03-17 — Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results | Neuronetics Inc (neuronetics.com)
2025-11-12 — TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression | Neuronetics Inc (neuronetics.com)
Company details
The company trades publicly as STIM and in April 2026 saw Optum/United Behavioral Health expand coverage of NeuroStar TMS to psychiatric mental health nurse practitioners. Neuronetics, Inc. was founded in 2003, has an estimated 500-1,000 employees, and is headquartered in Malvern, Pennsylvania.
Frequently asked questions
What does Neuronetics, Inc. do?
Neuronetics, Inc. is a medical technology company headquartered in Malvern, Pennsylvania, founded in 2003 and listed publicly under the ticker STIM. It employs between 500 and 1,000 people and reports revenue in the range of $149.2 million. The company develops transcranial magnetic stimulation systems for treating psychiatric and neurological conditions, including major depressive disorder. Its products serve the healthcare and medical equipment sector. In 2026 it announced a strategic collaboration with ANT Neuro, a neurotechnology firm.
Where is Neuronetics, Inc. headquartered?
Neuronetics, Inc. is headquartered in Malvern, Pennsylvania (3222 Phoenixville Pike, Malvern, Pennsylvania, 19355).
When was Neuronetics, Inc. founded?
Neuronetics, Inc. was founded in 2003.
How big is Neuronetics, Inc.?
Neuronetics, Inc. has an estimated 500-1,000 employees, with revenue in the 149.2M range.
Is Neuronetics, Inc. publicly traded?
Publicly traded (NASDAQ: STIM). Public financial figures are drawn from its filings.
Does Neuronetics, Inc. import from overseas suppliers?
US customs bill-of-lading records show 83 inbound shipments for Neuronetics, Inc., with top origins including China · Netherlands · Germany · Belgium.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.